Progress in the Challenge to Regulate Online Pharmacies by Karberg, Jeff
Cleveland State University
EngagedScholarship@CSU
Journal of Law and Health Law Journals
2010
Progress in the Challenge to Regulate Online
Pharmacies
Jeff Karberg
Follow this and additional works at: https://engagedscholarship.csuohio.edu/jlh
How does access to this work benefit you? Let us know!
This Note is brought to you for free and open access by the Law Journals at EngagedScholarship@CSU. It has been accepted for inclusion in Journal of
Law and Health by an authorized editor of EngagedScholarship@CSU. For more information, please contact library.es@csuohio.edu.
Recommended Citation
Note, Progress in the Challenge to Regulate Online Pharmacies, 23 J.L. & Health 113 (2010)
113 




 I. INTRODUCTION .................................................................... 113 
 II. TYPES OF ONLINE PHARMACIES............................................ 115 
 III. EXISTING LEGISLATION........................................................ 118 
 A. About the Regulatory Agencies.................................... 118 
 B. An Analysis of the Ryan Haight Online Pharmacy  
  Consumer Protection Act of 2008................................ 122 
 1. Strengths of the Ryan Haight Act......................... 123 
 2. DEA endorsement ................................................ 123 
 a. Transparency and Notice .............................. 125 
 b. Striking a Balance Between State and  
  Federal Authority .......................................... 127 
 3. Where the Ryan Haight Act falls short................. 128 
 a. Unnecessary Legislation ............................... 128 
 b. Failure to Address Crucial Aspects of Online  
  Pharmacies.................................................... 131 
 IV. RECOMMENDATIONS FOR FUTURE LEGISLATION ................. 132 
 A. Web Intermediaries...................................................... 132 
 B. Patient Privacy ............................................................ 134 
 C. Foreign Pharmacies .................................................... 135 
 D. Lifestyle Drugs............................................................. 137 
 E. Drug Manufacturers .................................................... 139 
 V. WHY THE RYAN HAIGHT ACT WILL BE SUCCESSFUL.......... 140 
 A. Online Banking ............................................................ 140 
 B. Increasing Role of the Internet .................................... 142 
 VI. CONCLUSION........................................................................ 142 
 
I.  INTRODUCTION 
Imagine for a moment that after borrowing a credit card, a teenager strolls down 
the block to the local pharmacy.  At the pharmacy, a doctor is at the door waiting and 
willing to prescribe anything to anyone.  After answering a few questions, the 
teenager receives his prescription, where he takes it to the drug counter and places an 
order for a dangerous amount of painkillers.   Imagine further that the teenager 
develops an addiction to the drugs and purchases an increased dosage each visit until 
finally, the teen dies from an overdose from the easily obtained prescription drugs. 
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The situation described above is drawn from a real event.1  Nearly the very same 
chain of events happened to seventeen year old Ryan Haight.  The only difference 
was that Ryan never even had to leave his home.  Ryan visited an online pharmacy 
and obtained a prescription from a doctor he had never met for drugs he did not need.  
Using his father’s credit card, Ryan had the drugs delivered to his home.2  Tragically, 
Ryan became addicted to the drugs and eventually died of an overdose at age 
eighteen.3  
Ryan’s tragic story was preventable.  There are ample barriers and regulations in 
place that would have prevented Ryan’s death if he had tried to obtain the drugs at 
his local pharmacy rather than one he found online.4  The need for the government to 
regulate online pharmacies is well documented,5 yet the federal government has 
largely avoided any meaningful regulation until passing the Ryan Haight Online 
Pharmacy Consumer Protection Act in October of 2008.6   
The transition from brick and mortar storefronts into cyberspace has presented 
both opportunities and challenges.  This is especially true for online pharmacies, 
where medicine and technology come together in a relatively new way.  Online 
pharmacies present a unique challenge by creating a tension between providing 
inexpensive remote heath care and the safety of in person health care.  
The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 is the first 
federal bill passed specifically to regulate online pharmacies.   In this note, I will 
identify the strengths and weaknesses of the Ryan Haight Online Pharmacy 
Consumer Protection Act of 2008 (the “Ryan Haight Act” or the “Act”) and make 
suggestions for future online pharmacy legislation.   
Part II of this note provides background information about online pharmacies.  
Part III discusses the agencies responsible for online pharmacy regulation and 
explains existing federal regulation.  In explaining the existing online pharmacy 
regulation, Part III of this note also identifies the strengths and weaknesses of the 
federal regulation.  Part IV provides suggestions for future online pharmacy 
legislation.  Part V of the note is a short explanation of how online pharmacies will 
be successfully regulated through federal registration. This note concludes that the 
                                                                 
1 Ryan’s Cause, http://www.ryanscause.org (last visited April 15, 2010.).  Ryan began 
using the drugs when he was seventeen years old.  Ryan’s parents, both of whom worked in 
the medical field, were shocked to discover that the highly regulated drugs they work with 
every day were so easily obtained.   Since 2001, Ryan’s friends and family have worked to 
further the cause of online pharmacy regulation.  Id.  
2 Id. 
3 Id. 
4 United States v. Fuchs, 467 F.3d 889, 899 (5th Cir. 2006) (“Section 841(a)(1) makes it 
‘unlawful for any person knowingly or intentionally. . .  to manufacture, distribute, or dispense 
. . .  a controlled substance.’” (quoting United States v. Moore, 423 U.S. 122, 124 (1975))). 
5 See generally Phil Ayers, Prescribing a Cure for Online Pharmacies, 72 TENN. L. REV. 
949 (2005); Ludmila Bussiki Silva Clifton, Internet Drug Sales: Is It Time To Welcome “Big 
Brother” Into Your Medicine Cabinet?, 20 J. CONTEMP. HEALTH L. & POL’Y 541 (2004); 
Kristin Yoo, Self-Prescribing Medication: Regulating Prescription Drug Sales on the Internet, 
20 J. MARSHALL J. COMPUTER & INFO. L. 57 (2001). 
6 110 P.L. 425 (Oct. 15, 2008). 
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current federal regulation of online pharmacies provides much needed progress but 
must be improved to ensure adequate protection. 
II.  TYPES OF ONLINE PHARMACIES 
Generally speaking, “[o]nline pharmacies are divided into three broad categories: 
traditional online pharmacy, prescribing-based site pharmacy, and rogue pharmacy.”7  
The traditional pharmacies are little more than an online extension of brick and 
mortar pharmacies.8  Often, this type of pharmacy is a nationally known or 
recognized chain.  Traditional online pharmacies require a prescription before an 
order for medicine will be filled or delivered.9    
Traditional online pharmacies place value on consumer protection and have self-
imposed standards that are commonly more protective than the regulations the Ryan 
Haight Act will put in place.  CVS and Walgreens provide two well-known examples 
of traditional pharmacies.  Traditional online pharmacies place value on consumer 
protection and have self-imposed standards that are more commonly more protective 
than the regulation that what the Ryan Haight Act will put in place.  The National 
Association of Boards of Pharmacy, a non-government association that rates online 
pharmacies, developed the Verified Internet Pharmacy Practice Sites (VIPPS).10  The 
VIPPS program was developed “[i]n response to public concern of the safety of 
pharmacy practices on the Internet.”11  Eligible online pharmacies display a seal 
prominently on the front page of their site after VIPPS accreditation.12  To earn 
VIPPS accreditation, a pharmacy must “comply with the licensing and inspection 
requirements of their state and each state to which they dispense pharmaceuticals.”13  
Furthermore, the pharmacies must demonstrate compliance with “VIPPS criteria 
including patient rights to privacy, authentication and security of prescription orders, 
adherence to a recognized quality assurance policy, and provision of meaningful 
consultation between patients and pharmacists.”14  Many of the VIPPS requirements 
go above and beyond the Ryan Haight Act’s requirements for online pharmacies. 
                                                                 
7 20 J. Contemp. Health L. & Pol'y 541 at 546.  
8 Id. 
9 Id. 
10 Verified Internet Pharmacy Practice Sites (VIPPS) – The National Association of 
Boards of Pharmacy, http://vipps.nabp.net/verify.asp (last visited Feb. 12, 2009).  The VIPPS 
program was created by the National Association of Boards of Pharmacy (NABP).  The 
NABP was established over 100 years ago to “assist state licensing boards in developing, 
implementing, and enforcing uniform standards to protect the Public Health.”  The NABP has 
member boards from every state.  Canada and Australia are also represented in the association.  
Internet consumers may check online pharmacies for VIPPS accreditation by simply entering 
the website URL in a site-checker. Id. 
11 Id. 
12 Id. 
13 Id.  
14 Id.  
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A second category of online pharmacy, prescribing-based, is a remote 
consultation pharmacy.15 This type of pharmacy will often provide both the 
prescription and the medication.16  A customer obtains a prescription after filling out 
a short questionnaire that is subsequently reviewed by a doctor for approval.17  
Because the doctors are often affiliated with the pharmacy site, most of the 
prescriptions are approved.18  Remote consultation pharmacies will be most affected 
by the Ryan Haight Act.19 
To some, remote consultation pharmacies are a legal gray area.20  Under good 
faith operation, these pharmacies potentially offer consumers the most convenience, 
privacy, and savings.21  A well-informed consumer would be able to address all of 
his or her pharmacy needs through one stop shopping.  The problems associated with 
remote consultation pharmacies are potentially deadly when any of the parties 
involved act with malicious, negligent or improper motives.  For example, the 
consumer may be self-diagnosing a serious medical problem incorrectly or may fill 
out the online questionnaire dishonestly.  Or perhaps the doctor, who is often paid 
for each prescription dispensed, over-prescribes the patients so that he or she may 
make more money.  Worse yet, the entire website may be a sham pharmacy designed 
simply to sell pills to addicts.  The Ryan Haight Act will address many of these 
                                                                 
15 Ancier v. Dep't of Health, Med. Quality Assurance Comm'n, 140 Wn. App. 564, 568 
(Wash. Ct. App. 2007). “Applicants must attest they have undergone recent physical 
examinations, will schedule routine physicals for the duration of the prescription, and will 
consult local physicians or pharmacists about any adverse reactions or complications.” Id.  
16 Trust-Meds.com, http://www.trust-meds.com/faq.php#q12, (last visited Feb. 16, 2009); 
Best E-Pharm.com, http://www.bestepharm.com/faq.php?cat=faq#200 (last visited Feb. 16, 
2009).  The above websites are examples of remote consultation pharmacies that were 
operational at the time of submission.   
17 See Ancier, supra note 15.  Consumers obtained prescriptions by filling out a relatively 
simple questionnaire.  The questionnaire is then reviewed by a doctor.  In Ancier, the doctor 
reviewed some 200,000 requests and issued 180,000 prescriptions in a three year period.  The 
doctor did not physically examine any of the consumers receiving prescriptions. Some 
consumers described their medical conditions as “Need [medication].”  Id.  
18 Id. “Between 2001 and 2004, [the doctor] reviewed approximately 200,000 requests and 
issued 180,000 prescriptions.  [The doctor] did not physically examine or personally interview 
any of the persons receiving the prescriptions.”  Id. 
19 See generally Ryan Haight Online Pharmacy Consumer Protection Act of 2008, 110 
P.L. 425 (Oct. 15, 2008).     
20 Donald Cooley, InternetDrugLaw.com, http://internetdruglaw.com/topics/ryan-haight-
act/ (Last visited Feb. 12, 2009). (Donald R. Cooley is a criminal defense attorney who posts 
recent developments concerning internet drug laws on his blog.  In many of his posts, Cooley 
argues that online pharmacies were legal before the Ryan Haight Act was signed into 
legislation.). 
21 PharmacyChecker.com: About Online Pharmacies, http://www.pharmacychecker.com/ 
aboutop.asp (last visited Mar. 24 2009).  The benefits of remote consultation pharmacies 
include lower prices, privacy, greater access to generic products, convenience, and medical 
information.  Id.  
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concerns in an attempt to clarify the government’s stance on the legality of remote 
consultation pharmacies.22 
A third online pharmacy category is the “rogue pharmacy.”23  The defining 
characteristic of a rogue pharmacy is that medication is dispensed without a 
prescription.24  Rogue pharmacies are considered extremely dangerous and are 
currently illegal.25  Many of them operate from outside of the United States.26  Rogue 
pharmacy customers are often the targets of fraud and counterfeit medicine.27  There 
is little difference between this type of pharmacy and back alley drug dealers.28 
Although rogue pharmacies are a threat to the safety of internet pharmacy 
consumers, the government’s stance on them is clear.  When the government 
becomes aware of rogue pharmacies, they are shut down and the operators are 
prosecuted.29  The Ryan Haight Act may have some effect on rogue pharmacies, 
particularly through the amendment that will increase the length of prison sentences 
for convicted parties.30  However, the Ryan Haight Act will not substantively change 
the way consumer, the government, and rogue online pharmacies interact.31 
                                                                 
22 Government Technology, http://www.govtech.com/gt/419355 (last visited Mar. 24, 
2009).  “Rather than try to block all online pharmaceutical sales, the Ryan Haight Act will put 
online pharmaceutical sales on an equal regulatory footing with those sales through a brick-
and-mortar facility.”  Id. 
23 Ayres, supra note 5, at 954.  
24 5 Star Pharma, http://www.fivestarpharma.com/ (last visited Feb. 16, 2009).  5 Star 
Pharma is an example of a rogue pharmacy website that was operational at the time of article 
submission.  The website is based outside of the United States and purports to mail controlled 
substances without a prescription.  Id.  
25 Online rogue pharmacies still booming, MSNBC.Com, http://www.msnbc.msn.com/id/ 
20409515/ (last visited Mar. 24, 2009).  Rogue pharmacies often approach retired or in debt 
doctors and offer them an opportunity to review prescription questionnaires.  Doctors are 
generally paid about 20 dollars for each prescription.  The prescriptions are then sent to 
pharmacies willing to fill them. Id.  
26 Dispensing and Purchasing Controlled Substances over the Internet, 66 Fed. Reg. 82, 
21181, 82 21184 (Apr. 27, 2001) (notice as to application of current laws related to 
dispensing, purchasing, or importing controlled substances).  Rogue online pharmacies are 
particularly dangerous because they often intentionally mislead consumers.  The DEA warns 
that “[t]hese sites often advise that there have been changes to the U.S. law that authorize the 
customer to import a controlled substance into the United States without benefit of a 
prescription.”   Dispensing and Purchasing Controlled Substances over the Internet.  
27 Food and Drug Administration, Counterfeit Drugs Questions and Answers, 
http://www.fda.gov/oc/initiatives/counterfeit/qa.html (last visited Dec. 2, 2008).  The Food 
and Drug Administration (FDA) credits the strong regulatory framework of the United States 
for low occurrence of counterfeit medicine.  Consumers who purchase drugs from foreign 
entities are therefore more likely to receive counterfeit drugs.  A counterfeit drug is a drug 
sold under an improper name.   Counterfeit drugs may contain dangerous incorrect ingredients 
that may have deadly side effects.   Id. 
28 See Dispensing and Purchasing Controlled Substances over the Internet, supra note 26. 
29 Id.  
30 See 21 U.S.C. § 841 et seq. “[I]n the case of any controlled substance in schedule III, 
such person shall be sentenced to a term of imprisonment of not more than 10 years and if 
118 JOURNAL OF LAW AND HEALTH [Vol. 23:29 
III.  EXISTING LEGISLATION 
A.  About the Regulatory Agencies 
Online pharmacies face federal regulation primarily from the United States Food 
and Drug Administration (FDA) and the United States Drug Enforcement 
Administration (DEA).32  Currently, the FDA regulates online pharmacies through 
the Federal Food, Drug, and Cosmetic Act (FD&C).33  The DEA regulates online 
pharmacies through the Controlled Substances Act of 1974.34  The agencies regulate 
different aspects of online pharmacies.  The FDA tends to regulate non-controlled 
substances while the DEA regulates controlled substances. The two agencies often 
work together; for example, the “FDA assists DEA in deciding how stringent DEA 
controls should be on drugs that are medically accepted but that have a strong 
potential for abuse.”35 
According to its mission statement, the FDA is “is responsible for protecting the 
public health by assuring the safety, efficacy, and security of human and veterinary 
drugs, biological products, medical devices, our nation’s food supply, cosmetics, and 
products that emit radiation.”36  The FDA officially came into existence after the 
                                                                                                                                         
death or serious bodily injury results from the use of such substance shall be sentenced to a 
term of imprisonment of not more than 15 years” Id.  
31 See generally Dispensing and Purchasing Controlled Substances over the Internet, supra 
note 26.  In the eyes of the federal government and the DEA, rogue pharmacies have always 
been considered illegal and a danger to consumer health.   Id.  
32 What FDA Doesn’t Regulate, http://www.fda.gov/AboutFDA/WhatWeDo/WhatFDA 
DoesntRegulate/default.htm  (last visited Apr. 12, 2010).  The DEA also “establishes limits on 
the amount of [prescription drugs that have a strong potential for abuse] that are permitted to 
be manufactured each year.”   Id.   
33 See Federal Food, Drug and Cosmetic Act, 21 U.S.C. 331 (2007).  Relevant to online 
pharmacy regulation, the FD&C prohibits “[t]he introduction or delivery for introduction into 
interstate commerce of any food, drug, device, or cosmetic that is adulterated or misbranded.” 
Id.  It also prohibits “[t]he doing of any act which causes a drug to be a counterfeit drug, or the 
sale or dispensing, or the holding for sale or dispensing, of a counterfeit drug.” Id. 
34 21 U.S.C. § 801 et. seq.  
35 Linda Bren, Agencies Team Up in War Against Internet Health Fraud, http://www.fda. 
gov/Drugs/EmergencyPreparedness/BioterrorismandDrugPreparedness/ucm137264.htm.  The 
Federal Trade Commission (FTC) has played a somewhat smaller role in regulating online 
pharmacies.  In 2001, the FTC created “Operation Cure.All” to crack down on companies 
making fraudulent health product claims.  Operation Cure.All resulted in numerous product 
seizures and recalls, arrests, and convictions.  Id.  
36 FDA’s Mission Statement, http://www.fda.gov/opacom/morechoices/mission.html (last 
visited Feb. 12, 2009).  A portion of the FDA’s Mission Statement reads : 
The FDA is responsible for protecting the public health by assuring the safety, 
efficacy, and security of human and veterinary drugs, biological products, medical 
devices, our nation’s food supply, cosmetics, and products that emit radiation. The 
FDA is also responsible for advancing the public health by helping to speed 
innovations that make medicines and foods more effective, safer, and more affordable; 
and helping the public get the accurate, science-based information they need to use 
medicines and foods to improve their health. 
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Wiley Act was passed in 1906.37  The Wiley Act placed the Bureau of Chemistry in 
charge of label regulation.38  At its inception, and until 1912, the FDA was primarily 
focused on regulating food, rather than drug products.39 
The FD&C was first passed in 1938 after a series of tragic and needless deaths.40  
The FD&C “brought cosmetics and medical devices under control, and it required 
that drugs be labeled with adequate directions for safe use . . . and mandated pre-
market approval of all new drugs.”41  This meant that drugs needed FDA approval 
before manufactures or anyone else could sell them.42  The FDA regularly uses these 
provisions as its foundation in online pharmacy regulation.43  A common scenario 
where the duty to regulate an online pharmacy falls on the FDA usually involves a 
website purporting to sell cures for cancer, AIDS, etc. 
The FDA has dedicated extensive effort toward educating the public concerning 
the risks and benefits of purchasing medicine from an online pharmacy.44  Aware of 
the rapid increase in online pharmacy sales,45 the FDA’s praise of online pharmacies 
                                                                 
37 John P. Swann, FDA History—Part I: The 1906 Food and Drugs Act and Its 
Enforcement, http://www.fda.gov/AboutFDA/WhatWeDo/History/Origin/ucm054819.htm 
(last visited Oct. 31, 2009).  After 1912, the Bureau of Chemistry focused its efforts on “patent 
medicines” in an increased effort to regulate drugs.  Although frustrated by regulatory laws, 
“seizures of misbranded and adulterated drugs nevertheless increased in the 1920s and 1930s.”  
Id.; What FDA Regulates, http://www.fda.gov/comments/regs.html (last visited Feb. 12, 
2009).  Currently, the FDA regulates a wide array of products.  Categorically, the FDA 
regulates biologics, cosmetics, drugs, foods, medical devices, radiation-emitting electronic 
products, and veterinary products.  Id.  
38 Id.   
39 Id.  
40 Id.  
41 Id.   
42 Id. 
43 Id.  
44 Buying Prescription Medicine Online: A Consumer Safety Guide, 
http://www.fda.gov/Drugs/ResourcesForYou/ucm080588.htm (last visited Oct. 31, 2009).   
One example of the effort to educate internet consumers, offers a practical guide that explains 
the basic risks and recommendations when dealing with an online pharmacy.  Id. The guide 
breaks down the different risks of the websites versus the risks of the medicine.  Id. Website 
risks include dealing with an unlicensed body a potential lack of privacy.  Id. Medicine risks, 
however, pose serious health risks.  Id. The FDA also advises consumers to meet and talk to 
their doctor.  Id. Finally, the guide provides links to reputable websites designed to help 
consumers find legitimate online pharmacies, as well as links to additional online pharmacy 
consumer education information.  Id.  
45 William K. Hubbard gave testimony before the United States House of Representatives 
in an effort to bring the major issues associated with the growing online pharmacy industry to 
light.  Hubbard explained that “[w]ith greater and greater frequency, consumers are using the 
Internet to access health related information and products. Sales of consumer products over the 
Internet have grown rapidly, including the sale of drugs.”  Internet Prescription Drugs: 
Hearing Before the H. Comm. On Government Reform 108th Cong. (2004) (statement of 
William K. Hubbard, Associate Comm’r for Policy and Planning, Food and Drug 
Administration). 
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exclaim that pharmacies have provided “significant benefits to consumers.”46  
William K. Hubbard, of the FDA, testified before the United States House of 
Representatives that “[m]any managed health care organizations are … turning to 
online prescription plans as a means of providing quality service at a lower cost.”47  
The advantages offered by online pharmacies include convenient and open access to 
drugs for disabled or homebound consumers, wider selection, lower prices, 24-hour 
shopping, and privacy.48  Additionally, technological aspects such as e-mail 
reminders, hyperlinks, and access to drug information can be substantial advantages 
over brick and mortar pharmacies.49 
The FDA devotes comparatively little effort praising online pharmacies in 
relation to the effort spent warning consumers concerning the risks of purchasing 
medicine through an online pharmacy.  Much of the FDA’s concern relates to the 
practices of remote consultation and rogue pharmacies.  The FDA describes these 
pharmacies as “a serious potential threat to the health and safety of American 
citizens.”50  The list of FDA risk concerns from internet pharmacies includes 
dangerous side effects from incorrect prescriptions, dangerous drug interactions, 
drug contamination, outdated and counterfeit drugs.51 
                                                                 
46 Id.   
47 Hubbard’s statement in full reads: “The growth in online drug sales by reputable 
pharmacies has provided significant benefits to consumers. Many managed health care 
organizations are searching for ways to achieve cost savings and are turning to online 
prescription plans as a means of providing quality service at a lower cost.”  Id.     
48 Id.  
49 Expanding on the benefits of online pharmacies, Hubbard explained that the internet 
offers advantages in the amount of information available and the ease of obtaining it, for 
example “detailed information on drug interactions . . .  e-mail [notification] if the drug they 
ordered has been recalled [or] a cheaper generic version of the drug becomes available . . .  
[h]yperlinks and search programs [that] provide online customers with written product 
information and references to other sources of health information more easily than in the 
traditional storefront.”  Id. 
50 Nearly five years before the Ryan Haight Act becomes effective, Hubbard’s testimony 
makes clear that federal regulatory agencies, such as the FDA, were aware of the need to 
regulate online pharmacies well before the Ryan Haight Act was passed.  Id.  Hubbard cites 
the American Medical Association and the Federation of State Medical Boards as other 
regulatory agencies advocating for online pharmacy regulation.  Id.  Hubbard specifically 
describes the dangers of using remote consultation pharmacies as “practicing what amounts to 
self-diagnosis” and a means to bypass regulation. Id.  Before the Ryan Haight Act, the only 
piece of internet pharmacy targeted legislation, the FDA was limited to advocating voluntary 
regulatory regimes, such as VIPPS.  Id.  Any FD&C Act violations perpetuated by online 
entities were handled as if it “were . . . another sales medium, such as a storefront or a 
magazine.” Id.  The testimony offered before the U.S. House of Representatives should have 
been a wakeup call to legislators about the dangers of access to unregulated medicine and 
controlled substances.  Id.  
51 Id.  
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The duty to regulate controlled substances was initially that of the FDA through 
the Drug Abuse Control Amendment of 1965.52  The Drug Abuse Control 
Amendment gave the FDA “control over amphetamines, barbiturates, hallucinogens, 
and other drugs of considerable abuse potential.”53  However, the duty to regulate 
controlled substances was eventually delegated to the DEA.54 President Nixon 
created the DEA through an executive order in 1973.55  The DEA regulates “[i]llegal 
drugs with no approved medical use--such as heroin and marijuana.”56  The mission 
statement of the DEA requires the DEA to “enforce the controlled substances laws 
and regulations of the United States.”57 
Both the DEA and FDA have published guides to educate consumers about the 
risk and benefits of online pharmacies.58  These guides offer tips on safety, the law, 
and what to look for in a reputable online pharmacy.59 For example, the FDA 
                                                                 
52 John P. Swann, FDA History—Part III: Drugs and Foods Under the 1938 Act and Its 
Amendments, http://www.fda.gov/AboutFDA/WhatWeDo/History/Origin/ucm.055118.htm 
(last visited Oct. 31, 2009). 
53 Id. 
54 Id.  
55 Id.    
56 United States Food and Drug Administration, What FDA Does Not Regulate, 
http://www.fda.gov/comments/noregs.html (last visited Feb. 12, 2009). 
57 U.S. Drug Enforcement Administration, DEA Mission statement, http://www.usdoj.gov/ 
dea/agency/mission.htm (last visited Feb. 12, 2009).  The mission statement of the DEA reads:  
The mission of the Drug Enforcement Administration (DEA) is to enforce the 
controlled substances laws and regulations of the United States and bring to the 
criminal and civil justice system of the United States, or any other competent 
jurisdiction, those organizations and principal members of organizations, involved in 
the growing, manufacture, or distribution of controlled substances appearing in or 
destined for illicit traffic in the United States; and to recommend and support non-
enforcement programs aimed at reducing the availability of illicit controlled 
substances on the domestic and international markets. 
58 The United States Food and Drug Administration, The Possible Dangers of Buying 
Medicines Over the Internet, http://www.fda.gov/ForConsumers/ConsumerUpdates/ 
ucm048396.htm (last visited Apr. 15, 2010). In yet another effort to inform consumers, the 
FDA provides easy to read material that explains how consumers can identify whether or not 
an online pharmacy or its products are legitimate.  Id.; Drug Enforcement Administration, 
Office of Division Control, Questions and Answers: Dispensing and Purchasing Controlled 
Substances Over the Internet, http://web.archive.org/web/20080722205257/http://www.dea 
diversion.usdoj.gov/faq/internetpurch.htm  (last visited Apr. 15, 2010).   The DEA also 
provides consumer friendly and easy to read materials regarding online pharmacies.  However, 
the material from the DEA tends to focus on the criminal aspects concerning rogue 
pharmacies, whereas the FDA focused on potential health risks.  The DEA correctly identifies 
one of the major issues for rogue sites – many consumers are unaware that they are breaking 
the law.  The educational material is an effort to prevent, rather than punish, those sorts of 
crimes.  Id.   
59 The United States Food and Drug Administration, The Possible Dangers of Buying 
Medicines Over the Internet, http://www.fda.gov/ForConsumers/ConsumerUpdates/ 
ucm048396.htm (last visited Feb. 12, 2009); Drug Enforcement Administration, Office of 
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recommends that the pharmacy should be licensed, located in the United States, 
require a prescription, and have a pharmacist available for any questions or 
concerns.60  In a similar vein, the DEA advises consumers on common traits of 
unsafe websites.61  Unsafe websites are often eager to offer to import illegal or 
dangerous drugs without a valid prescription.62 
B.  An analysis of The Ryan Haight Online Pharmacy Consumer Protection Act of 
2008 
The Ryan Haight Act addresses several issues. Primarily, the Act adds to and 
amends several sections of the Controlled Substances Act.63  The additions and 
amendments are specifically directed towards online pharmacies.64  These additions 
are significant because the Ryan Haight Act is really the first piece of major 
legislation to address online pharmacies directly.  The Act reflects both a change in 
environment and legislative direction. 65   
The DEA’s press release highlights six prominent features of the Act,66 which 
will be discussed in depth later in the note.  The Act will: (1) require face to face 
                                                                                                                                         
Division Control, Questions and Answers: Dispensing and Purchasing Controlled Substances 
Over the Internet http://web.archive.org/web/20080722205257/http://www.dea diversion. 
usdoj.gov/faq/internetpurch.htm  (last visited Apr. 15, 2010).     
60 Drug Enforcement Administration, Office of Division Control, Questions and Answers: 
Dispensing and Purchasing Controlled Substances Over the Internet, http://web.archive.org/ 
web/20080722205257/http://www.deadiversion.usdoj.gov/faq/internetpurch.htm  (last visited 
Apr. 15, 2010).    
61 Id.  
62 Id. The DEA provides notice of the laws relevant to importing controlled substances 
with “The Controlled Substances Act prohibits any person from importing into the customs 
territory of the U.S. any controlled substance or List I chemical (21 U.S.C. § 971) and (21 
CFR part 1313) unless that person maintains a valid, current authorization to import such 
substances or chemicals (21 U.S.C. 957(a)).  Illegal importation of controlled substances is a 
felony that may result in imprisonment and fines (21 U.S.C. 960).  Id.  
63 110 P.L. 425 (Oct. 15, 2008).    The Ryan Haight Act amends 21 U.S.C. § 801, 21 
U.S.C. § 802, 21 U.S.C. § 823, 21 U.S.C. § 827, 21 U.S.C. § 829, 21 U.S.C. § 831, 21 U.S.C. 
§ 841, 21 U.S.C. § 843, 21 U.S.C. § 882,  and 21 U.S.C. § 960. Id.  
64 See generally 21 U.S.C. § 831 et seq; Mike Pramik, New Law regulates internet drug 
sales, The Columbus Dispatch, http://www.columbusdispatch.com/live/content/business/ 
stories/2008/10/17/Internet_pharmacy_law.ART_ART_10-17-08_C12_SUBKEQK.html?sid= 
101 (last visited Mar. 25, 2009).  “Before the law was enacted, the legal definition of what 
constitutes a prescription had been left to state pharmacy boards.” Id.  
65 110 P.L. 425 (Oct. 15, 2008).  While the legislation places online pharmacies on the 
same regulatory regime as brick and mortar pharmacies, it includes many internet specific 
provisions. Id.   
66 DEA News: Congress Passes Ryan Haight Online Pharmacy Consumer Protection Act, 
http://www.prweb.com/releases/DEA/Pharmacy_Act/prweb1409764.htm (last visited Dec. 2, 
2008).  At the time of the press release, the Act had not been formally signed into legislation 
by President Bush.  DEA Administrator Michele Leonhart stated "[t]his landmark piece of 
legislation will bring rogue pharmacy operators out of the shadows by establishing a clear 
standard for legitimate online pharmaceutical sales. The legislation will allow customers to 
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medical examination before a prescription is issued, (2) require DEA endorsement 
for pharmacies, (3) increase penalties for distributing certain drugs, (4) prohibit 
advertising illegal drug sales, (5) require pharmacies to post relevant contact 
information, and (6) create a civil cause of action for state attorneys general.67  
1.  Strengths of the Ryan Haight Act 
2.  DEA Endorsement68 
Under the Controlled Substances Act, brick and mortar pharmacies that dispense 
Schedule II, III, IV, or V drugs69 must register with the Drug Enforcement 
Administration70 and state attorney generals.  Before the Ryan Haight Act, online 
pharmacies were not required to register with the DEA.  Online pharmacies were 
only required to register the “actual physical location of the pharmacy which 
purchases, stores and dispenses controlled substances pursuant to prescription orders 
processed by the Internet site.”71 Now, the DEA contends that online pharmacies will 
be put on “equal footing” with brick and mortar pharmacies by the Act because all 
DEA “shall modify the registration of pharmacies . . . to dispense controlled 
substances by means of the internet.”72  
                                                                                                                                         
know they are doing business with a trusted, legitimate pharmacy, and give law enforcement 
the tools we need to identify illegitimate online pharmacies."   Id. 
67 Id.  
68 21 U.S.C. § 823 (b) (2008).  Pharmacies registered to dispense controlled substances 
will have their registrations modified to “authorize them to dispense controlled substances by 
means of the internet”.  Id. 
69Dispensing and Purchasing Controlled Substances over the Internet, supra note 26, at 
21181.    
“Schedule II - Amphetamine, codeine, fentanyl, Hydromorphone, meperidine, methadone, 
Methylphenidate (Ritalin),morphine, oxycodone, pentobarbital, phencyclidine(PCP), 
secobarbital. 
Schedule III - Anabolic steroids, phendimetrazine, and productsthat contain small 
quantities of certain schedule II controlled substances, such as codeine, in combination with 
noncontrolled ingredients, such as aspirin. 
Schedule IV - Alprazolam (Xanax), chlordiazepoxide (Librium),diazepam (Valium), 
lorazepam (Ativan), phenobarbital, phentermine.  
Schedule V- Buprenorphine and many cough Preparations that contain a limited amount of 
codeine.”   
70 21 U.S.C. § 823 (2006).  This section of the Controlled Substances act also allows for 
distributor and manufacturers to forego the registration requirements in the name of public 
interest.    
71 21 U.S.C. § 823 (b) (2008); Dispensing and Purchasing Controlled Substances over the 
Internet, supra note 26, at 21182.  
72 DEA News: Congress Passes Ryan Haight Online Pharmacy Consumer Protection Act, 
supra note 66.  Online pharmacies are put on equal footing with brick and mortar pharmacies 
for regulatory purposes.  The Ryan Haight Act includes several internet specific provisions to 
facilitate the “equal footing”.  Id.  
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The problem before the legislation was evident in the relationship between the 
online pharmacies and the registered brick and mortar pharmacies. The registered 
pharmacies would “have little or no walk-in customers and do most or all of their 
business via rogue Internet sites.”73  This relationship enabled online pharmacies to 
bypass traditional methods of regulation.  Traditional DEA regulation would monitor 
entities that dispensed the controlled substances for violations of the law.  Before the 
Act, online pharmacies had full access to DEA regulated controlled substances 
without being registered with the DEA.  In other words, many of the pharmacies 
were simply off or under the radar of the regulating agencies. 
Pharmacist Tommy Fuchs presents a vivid illustration of the need for the federal 
registration requirement.  Fuchs established brick and mortar pharmacies in Texas 
and later in Oklahoma as front for his online pharmacy businesses.74  Fuchs’ online 
pharmacies, in turn, were merely a way to sell pain pills to addicts at an enormous 
profit.  At their peak, the pharmacies filled up to 500 prescriptions for controlled 
substances from the same doctor each day.75  The prescriptions commonly authorized 
the maximum number of refills, which allowed the consumer to receive as many pills 
as he or she wanted at a time and the pharmacy to make more money per 
transaction.76  Unfortunately, one of the prescriptions and refill combinations went to 
Ryan Haight, who was killed from an overdose of the medicine.77   
Fuchs’ original Texas pharmacy had been shut down by the Texas State Board of 
Pharmacy after the Board noticed a suspiciously high number of prescriptions were 
filled by the same doctor.78  The Texas Board took all of the necessary action it was 
authorized to do.79  Confined to act under laws designed to regulate brick and mortar 
pharmacies, the Texas Board was largely unable to prevent series of events that 
followed. Undeterred, Fuchs simply hopped the state line and picked up where he 
                                                                 
73 Id.  
74 United States v. Fuchs, 467 F.3d 889,898 (5th Cir. 2006).  Fuchs paid staff physicians 
between $40 and $70 for each prescription. Id. 
75 Id.  
76 Id. 
77 Testimony of Francine Haight: Hearing before the S. Comm. On the Judiciary, 110th 
Cong. (May 16, 2007), available at http://judiciary.senate.gov/hearings/testimony.cfm?id=275 
5&wit_id=6466 (last visited Feb. 12, 2009).  Francine Haight, Ryan Haight’s mother, testified 
before the Judiciary Committee.  In her testimony, Francine relived the events leading up to 
Ryan’s death, stating “Clayton Fuchs of Mainstreet Pharmacy, delivered [the drugs] to our 
home.”  Francine also read excerpts from letters she has received expressing public support for 
online pharmacy regulation.  Id.   
78 Fuchs, 467 F.3d at 897.  “Texas State Board of Pharmacy performed a routine 
inspection of [Fuchs’ pharmacy] . . .  [and] was troubled by the high volume of prescriptions. . 
. [and] also concerned that nearly all . . .  prescriptions were signed by the same doctor, who 
was located in Texas, [although his] patients were dispersed throughout the United States.”  
Id.   
79 Id. The Texas Board of Pharmacy Field Compliance Officer “informed Fuchs that the 
prescriptions generated through [the website] were invalid.”  Id. 
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left off.80  One month after being shut down in Texas, Fuchs opened an Oklahoma 
pharmacy under a different pharmacy name.  The Oklahoma pharmacy functioned in 
the nearly the exact manner as the Texas pharmacy - peddling drugs under a quasi-
legal entity.81  The pharmacies generated millions of dollars and Fuchs fueled 
addictions across the country by prescribing and shipping pills to whomever was 
willing to pay. 
The federal registration requirement is a much needed element of federal 
regulation.  The registration requirement in the Ryan Haight Act could have 
prevented the conduct described above. By requiring all internet sites to register, the 
DEA would be better able to monitor online pharmacies for illegitimate use.82  
Rather than searching the internet and investigating individual web sites, the DEA 
could now simply shut down any unregistered site as soon as it is discovered, 
precluding nefarious pharmacists from crossing state lines, opening a new pharmacy 
and resuming business as usual.   
The nature of the internet is far more conducive to federal regulation than state 
regulation.  The internet is the same for all users, regardless of whichever state a 
particular user happens to be a part of.  Federal agencies are not bound by arbitrary 
lines – they are free to regulate across all fifty states.  The DEA endorsement could 
also serve as a central database of valid online pharmacies.  Ideally, all valid 
websites would be readily ascertainable in one centralized source, perhaps setting the 
foundation for cooperation with other government agencies and business entities.  
Perhaps eventually a published list of DEA endorsed online pharmacies will be 
available to consumers as to promote safe online transactions.  The ability to check 
the endorsement status of a website may be very reassuring to new or inexperienced 
online patrons. 
a.  Transparency and Notice 
An additional strength of the Ryan Haight Act is that the Act itself serves as a 
notice of the government’s position on online pharmacies to the public.  The 
underlying theme of the government’s message is that all pharmacies will be held 
accountable to the same regulations and standards, notwithstanding their status as a 
digital or brick and mortar entity.83  For consumers, the Ryan Haight Act strives to 
                                                                 
80 Id.  A field compliance officer from the Texas State Board of Pharmacy performed an 
inspection of Fuchs’ pharmacy in August of 2000.  Id. The officer was troubled by the amount 
of prescriptions and the practice of having the same Texas doctor prescribe patients 
throughout the United States.  Id. The officer informed Fuchs that the prescriptions were 
invalid.  Fuchs subsequently closed the Texas pharmacy.  Id. In October 2000, just three short 
months after closing the original pharmacy, Fuchs opened his Oklahoma pharmacy.  Id.   
81 “[the Oklahoma pharmacy’s] operation was substantially the same as [the Texas 
pharmacy].”  Id. at 898.   “The pharmacy was processing between 300 and 500 prescriptions 
per day, approximately 70% of which were for hydrocodone.  And nearly every . . .  order was 
shipped out was a 30 day supply of 100 tablets with two refills.” Id.  
82 DEA News: Congress Passes Ryan Haight Online Pharmacy Consumer Protection Act, 
supra note 66.   
83 DEA News: Congress Passes Ryan Haight Online Pharmacy Consumer Protection Act, 
supra note 66.  The act will place online pharmacy sales “on an equal regulatory footing with 
those sales through a brick-and-mortar facility. The act requires an endorsement of an existing 
registration to allow existing pharmacies to sell controlled substances online . . . [L]aw 
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place online pharmacies on equal footing with brick and mortar pharmacies in terms 
of transparency, customer service and compliance with relevant laws.84  The Ryan 
Haight Act requires pharmacy websites to disclose information so commonplace in 
brick and mortar pharmacies that it may often go unnoticed.  For example, online 
pharmacies are now required to place contact and licensure information prominently 
on the home page.85  Increased transparency will ease the consumer concerns 
regarding the legality86 of the pharmacy and establish consumer trust.  While this 
aspect of the Ryan Haight Act will not deter criminals from trying to bypass 
controlled substance regulations, it will help consumers avoid falling prey to rogue 
website fraud. 
For prescribing doctors and pharmacists, the Ryan Haight Act serves as a notice 
of baseline professional conduct and as a warning for those who choose to act 
outside of professional conduct.  The Ryan Haight Act requires a valid prescription 
before any controlled substance is dispensed.87  A valid prescription requires at least 
one in-person medical evaluation,88 putting an end to remote consultation pharmacies 
as commonly practiced.  Remote consultation pharmacies relied on the doctor’s 
ability to issue prescriptions to whoever is willing to fill out a website 
questionnaire.89  Through the use of a questionnaire, one doctor was able to provide 
service to countless customers from all over the United States, keeping the cost of 
operating an online pharmacy to a minimum.90  It is clear that legislators believe the 
potential harm from remote consultation pharmacies outweighs the possible benefits 
of lower cost and at-home service. 
The Ryan Haight Act will change the willingness and ability of pharmacists and 
physicians to dispense drugs illegally.   Pharmacists and doctors that ignore 
minimum guidelines do so at their own peril.  Anyone caught violating the 
Controlled Substances Act will face steeper penalties than before.91 The scope of 
                                                                                                                                         
enforcement will be able to . . .  scrutinize all applications for such registration . . . easily 
separate . . .  illegitimate Internet operations.”  Id.   
84 21 U.S.C. §§ 831(c)(1-7) (2008) .  Online pharmacies are required to “post in a visible 
and clear manner” the name and address of the pharmacy, the pharmacy’s telephone number 
and email address, the name and degree and states of licensure of the pharmacist in charge, a 
list of states in which the pharmacist is licensed, and a certification that the pharmacy is 
registered to deliver, distribute, or dispense controlled substances over the internet.  Id.  
85 21 U.S.C. §831(c) 
86 Dispensing and Purchasing Controlled Substances over the Internet, supra note 26 at 
21183.  Under the heading “Are Internet Pharmacy Sites Legitimate?” the DEA encourages 
readers to confirm the legitimacy of any internet site before filling or ordering a prescription.    
87 21 U.S.C. § 829 (2008).   
88 Id.  “The term ‘valid prescription’ means a prescription that is issued for a legitimate 
medical purpose in the usual course of professional practice by -- a practitioner who has 
conducted at least 1 in-person medical evaluation of the patient. . . ” Id.  
89 See Ancier, supra note 15.   
90 Id. at 836. A remote consultation pharmacy is able to serve thousands of consumers 
from all over the United States through one doctor.  Id.   
91 21 § U.S.C.(b)(C, E). 
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punishable offenses under the Controlled Substances Act applies to all stages of 
participation in an online pharmacy – from writing the prescriptions to serving as an 
intermediary for buyers and sellers.92  DEA Administrator Michele Leonhart 
concludes that “[t]he legislation will allow customers to know they are doing 
business with a trusted, legitimate pharmacy.”93 
b.  Striking a Balance between State and Federal Authority94 
The Ryan Haight Act creates a state cause of action to better protect consumers 
and regulate online pharmacies.95  The problem before the Act was that “a state 
Attorney General's enforcement authority against an online pharmacy is limited to 
the geographic boundaries of that state, which causes significant challenges when a 
case involves illegal activity over the Internet.”96  Traditionally, pharmacies are 
regulated by state law while medicine is regulated by federal agencies.  States 
regulate pharmacies through practice licensure.  Once licensed by a particular state, 
pharmacies and pharmacists may dispense FDA regulated or DEA controlled 
substances.97 
The state cause of action “allows states to work together with each other and with 
the federal government to strike the correct balance that will afford consumers the 
greatest protection without eliminating the states’ traditional role in pharmacy 
                                                                                                                                         
Schedule III: Maximum sentence for first offenders from 5 years to 10 years; 
Maximum sentence for second offenders from 10 years to 20 years; 
Schedule IV: Maximum sentence for first offenders from 3 years to 5 years; 
Maximum sentence for second offenders from 6 years to 10 years; 
Schedule V:   Maximum sentence for second offenders from 2 years to 6 years. 
 
92 21 U.S.C. § 841 (2008). The Ryan Haight Act prohibits delivery and distribution of 
controlled substances by means of the internet, unless authorized by the DEA.  Some 
examples of delivery and distribution provided by the Act are “writing a prescription for a 
controlled substance for the purpose of delivery, distribution, or dispensation by means of the 
Internet” and “offering to fill a prescription for a controlled substance based solely on a 
consumer's completion of an online medical questionnaire.” 
93 DEA News: Congress Passes Ryan Haight Online Pharmacy Consumer Protection Act, 
supra note 66. 
94 21 U.S.C.§ 882 (2008).  “The State shall serve a copy of the complaint upon the 
Attorney General and upon the United States Attorney . . .  Upon receiving notice respecting a 
civil action pursuant to this section, the United States shall have the right to intervene in such 
action”. Id. 
95 Id.  
96 DEA News: Congress Passes Ryan Haight Online Pharmacy Consumer Protection Act, 
supra note 66. 
97 Hearing on Internet Drug Sales before the H. Comm. On Government Reform, 108th 
Congress (2004) (statement of William K, Hubbard, Associate Commissioner for Policy and 
Planning. 
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licensing and regulation.”98   Under the Act, any state that has reason to believe its 
residents may be adversely affected by an online pharmacy may bring civil action on 
behalf of state residents. 99  The civil action includes injunctive relief, damages, and 
enforcing compliance.100 The Act also allows for federal intervention if 
appropriate.101  The cooperation between state and federal government encourages 
flexibility necessary to regulate dangerous online entities.  State governments may be 
more able to become aware of a problem pharmacy more quickly than the federal 
government, but the federal government’s resources may be more effective in 
combating the problem. 
3.  Where the Ryan Haight Act falls short 
a.  Unnecessary legislation 
Unfortunately, much of the Ryan Haight Act is dedicated to unnecessary 
legislation.  In a press statement released when the Act was passed, the DEA touts 
six areas of the controlled substances act that are amended by the Ryan Haight Act 
that were intended to address the problems caused by online pharmacies.102  In 
reality, the Act does not do much in respect to combating rogue and remote 
consultation pharmacies in at least three of the areas highlighted by the DEA.  Those 
areas are the face–to-face requirement for valid prescriptions, a ban on advertising, 
and increased penalties for violating the act. 
Perhaps one of the most mentioned features of the Act requires a face-to-face 
meeting between the prescriber and the patient.103  The Act also prohibits advertising 
or offering to fill a prescription based solely on a questionnaire.104  In 2001, the DEA 
published a notice to establish guidelines for dispensing and purchasing controlled 
substances over the internet.105  In the notice the DEA stated that “[c]ompleting a 
                                                                 
98 Clifton, supra note 5, at 567. 
99 21 U.S.C.§ 882 (2008).   
In any case in which the State has reason to believe that an interest of the residents of 
that State has been or is being threatened or adversely affected by the action of a 
person, entity, or Internet site that violates the provisions [The Controlled Substances 
Act], the State may bring a civil action on behalf of such residents in a district court of 
the United States with appropriate jurisdiction. 
100 Id.  
101 Id.  
102See Press Release, DEA, supra note 66. 
103 21 U.S.C. § 829 (2008).  “No controlled substance that is a prescription drug as 
determined under the Federal Food, Drug, and Cosmetic Act may be delivered, distributed, or 
dispensed by means of the Internet without a valid prescription.”  A valid prescription requires 
“at least 1 in-person medical evaluation of the patient”.  Id.  
104 21 U.S.C. § 841 (2008).  The text of the Ryan Haight Act prohibits “offering to fill a 
prescription for a controlled substance based solely on a consumer's completion of an online 
medical questionnaire”.  Id. 
105 Dispensing and Purchasing Controlled Substances over the Internet, supra note 26. 
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questionnaire that is then reviewed by a doctor hired by the Internet pharmacy could 
not be considered the basis for a doctor/patient relationship.”106   
In 2005, the DEA released another publication addressing online pharmacies.107  
More specifically, the publication was an attorney’s bulletin explaining why remote 
consultation pharmacies are illegal.108 Further, the bulletin offers advice to 
prosecutors on successful theories of prosecution in combating remote consultation 
pharmacies.109  The illegality of remote consultation pharmacies had been established 
for nearly a decade before the Act’s effective date.   
Case law also suggests that the face-to-face meeting requirement in the Act is 
redundant.  In United States v. Nelson, a doctor employed by a remote consultation 
pharmacy was convicted of “conspiracy to distribute controlled prescription drugs 
outside the usual course of professional practice, in violation of 21 U.S.C. § 846” 
after filling prescriptions without a face to face meeting with his patients.110  The 
physician, Nelson, would review patient records and sign the prescriptions as 
required by federal law.  As online consumers filled out questionnaires and requests 
for prescription drugs, Nelson went to the actual brick and mortar location of the 
pharmacy to conduct a review of the orders, never speaking or meeting any of the 
consumers who had placed the order.  Some days, Nelson would review up to a 
thousand questionnaires.111  Nelson received compensation for “reviewing” the 
questionnaires from the owner of the pharmacy.  Nelson’s conduct was essentially 
equal to that of a drug dealer.  Customers came to him for drugs, and for a fee, he 
would aid them in obtaining them.  Nelson’s conduct resulted in a conviction for a 
violation of the Controlled Substances Act.112 
                                                                 
106 Id. at 21183. 
107 Id. 
108 See generally id. 
109Charlotte J. Mapes, Internet Pharmacies and the Unlawful Distribution of Controlled 
Substances, United States Attorney’s Bulletin, Volume 53 Number 5, September 2005 
available at http://www.usdoj.gov/usao/eousa/foia_reading_room/usab5305.pdf.  In the 
introduction to the step-by-step advice on how to prosecute online pharmacy operators, the 
author states that the Food, Drug, and Cosmetic Act and the Controlled Substances Act are 
used to prosecute drug distributors even though the internet was not in existence at the time of 
legislation.  Mapes proceeds to explain successful prosecution techniques.  Mapes concludes, 
“Internet pharmacy cases are being successfully prosecuted by Untied States Attorney’s 
Offices around the country.  Such prosecutions can have a substantial impact on the 
availability of these dangerous drugs. . . .”  Id. 
110 United States v. Nelson, 383 F.3d 1227 (10th Cir. Okla. 2004) (held that “the 
government  presented sufficient evidence from which a reasonable jury could find beyond a 
reasonable doubt that Nelson participated in a conspiracy to distribute prescription drugs 
outside the usual course of professional practice”). 
111 Mapes, supra note 109.  Nelson reviewed “exponentially more [prescriptions] than he 
could have written if he had seen and consulted with each patient before issuing a 
prescription.”  
112 Id.  Nelson, a physician, was convicted for conspiracy to distribute controlled 
prescription drugs outside the usual course of professional practice over the internet.  Nelson 
approved over up to 95% of all internet prescriptions without ever physically examining his 
patients.  The vast majority of the prescriptions were for schedule III painkillers.  Nelson 
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The court in Nelson used the very same statute the Ryan Haight Act amends to 
convict an internet pharmacist.113  Nelson’s conviction was based on a violation of 
laws established for brick and mortar pharmacists “acting outside the usual course of 
professional practice.”114 The violation of this standard was due in large part to his 
failure to conduct face-to-face meetings with his patients.  Several years later, 
Congress eventually passed legislation that required the face-to-face meeting in an 
effort to regulate rogue pharmacies.  By adding redundant and already established 
requirements, the Ryan Haight Act does not contribute in a meaningful way to 
improve online pharmacy regulation. 
In United States v. Fuchs, a pharmacist was convicted under the Controlled 
Substances Act for his participation in a remote consultation pharmacy for 
dispensing controlled substances via the internet to customers who received 
prescriptions based solely on questionnaires.115  Fuchs operated a remote consultation 
pharmacy where customers from anywhere in the United States could place orders 
for prescription medication through the use of a questionnaire.116  Once the 
questionnaires were complete, a prescription form was automatically created and 
sent to the on staff physician.117  After a cursory review, the physician would sign the 
form and authorize the prescription.  Fuchs paid the physician forty dollars for each 
signed prescription form.118  Fuchs’ website was, in essence, a method for consumers 
to bypass traditional restrictions on controlled substances for a small fee, much like 
that of a street corner drug dealer.119 
United States v. Lovin includes a discussion regarding dispensing controlled 
substances to customers who completed a questionnaire via the internet when the 
Ryan Haight Act was still pending legislation.120  The Lovin court concluded that the 
                                                                                                                                         
played an integral role in the rogue pharmacy scheme.  As the prescribing physician, Nelson 
personally signed thousands prescriptions to authorizing the pharmacy to distribute the 
painkillers.  Id.  
113 Id.  
114 United States v. Moore, 423 U.S. 122, 124 (1975). 
115 Fuchs, 467 F.3d 889,  898-899 (upholding conviction for conspiracy to distribute 
controlled substances).    
116 Id. “Customers located throughout the United States went to the pharmacy's web site, 
completed an online profile, and requested medication . . . [the doctor] reviewed the patient's 
profile and approved and signed the prescription without communicating with the patient 
either face to face or over the telephone.”  Id. at 897.  
117 Id.  
118 Id. Fuchs eventually increased the payment to online pharmacy doctors to 100 dollars 
per prescription after the size of the prescription was changed from 40 pills to 100 pills.  Id. at 
897. 
119 DEA News: Congress Passes Ryan Haight Online Pharmacy Consumer Protection Act, 
supra note 66.  “Rogue Internet pharmacies typically operate with active participation of an 
unscrupulous doctor who willingly issues prescriptions to "patients" throughout the country 
whom the doctor never sees and without a preexisting bona fide doctor-patient relationship.” 
Id.  
120 United States v. Lovin, 2008 U.S. Dist. LEXIS 80258, at *10-13 (S.D. Cal. Sept. 29, 
2008) (Citing Quinones, 536 F. Supp. 2d at 273). 
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indictment for violations of the Controlled Substances Act were valid even as 
legislation directly addressing the issues at hand sat unpassed in Congress, stating 
"[t]hat [even though] Congress has considered clearer legislation . . . does not mean 
that existing laws do not apply. . . ."121 Lovin, Fuchs, and Nelson demonstrate that 
participation in the operation of a remote consultation pharmacy is a violation of the 
Controlled Substances Act.  Formal legislation reaching this conclusion does not 
provide internet consumers any additional protection.  Some commentators are now 
advocating that the passage of the Ryan Haight Act indicates that remote 
consultation was previously legal and that current indictments should be thrown 
out.122  Legislators needed to expand and build on the scope of the existing online 
pharmacy regulation. 
Additionally, the increased penalties in the Act seem largely irrelevant.  The 
increase in prison time is irrelevant largely in part to the scale of the online pharmacy 
operations.  “Stiffer penalties on the sellers of these drugs will not make an 
appreciable dent in Internet sales. Most of the Web sites offering these drugs are 
hosted outside the United States, with the sellers well beyond the reach of U.S. law 
enforcement.”123  Successful online pharmacy prosecutions also often result in a wide 
array of criminal charges. Convictions for conspiracy, money laundering, and 
continuing criminal enterprise have all accompanied online pharmacy violations of 
the Controlled Substances Act.124 
b.  Failure to address Crucial Aspects of Online Pharmacies 
Although generally well received, the Act has generated some criticism.125  
Perhaps the largest weakness in the Ryan Haight Act is the failure to address 
important aspects of the online pharmacy industry.  Some of the omissions in the Act 
seem to suggest that the legislators lacked a fundamental understanding of the 
problems associated with online pharmacies and how they affect consumers.  Many 
of these problems and issues are well documented with private enterprises that rate 
the validity of online pharmacies.126  The Ryan Haight Act fails to address 
requirements regarding patient privacy, foreign pharmacies, search engines, and non-
controlled substances.   
The Ryan Haight Act fails to address any sort of financial or medical record 
requirement for websites.  Identity theft, fraud, and patient privacy are among the 
first concerns that come to mind for any online transaction, especially when dealing 
with health issues.  While striving to regulate online pharmacies in the same manner 
                                                                 
121 Id. at *12. 
122 See generally Donald Cooley, supra note 20. 
123 Mathea Falco and Philip Heymann, Fighting the Online Drug Corner, Washington 
Post, Mar. 15, 2008, at A13. 
124  Mapes, supra note 109. 
125 Sarah Rubenstein, New Bill Targets Rogue Druggists on the Internet , WALL ST. J., 
Oct. 9, 2008, at D1, available at http://online.wsj.com/article/SB122351521815117817.html 
?mod=googlenews_wsj (last visited Oct. 31, 2009). 
126 National Association of Boards of Pharmacy,  http://www.nabp.net/ (last visited Dec. 
5, 2008).  Pharmacy Checker.com, http://www.pharmacychecker.com/aboutop.asp (last visited 
Dec. 5, 2008).   
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as brick and mortar pharmacies, legislators have overlooked problems unique to the 
internet. 
Unregulated medication from foreign pharmacies also poses a threat to 
consumers.  Imported medication may be counterfeit, mislabeled, unsafe, or 
manufactured under dissatisfactory conditions.127  Non-controlled substances, often 
called “lifestyle drugs”128 include hair growth, weight loss, and sexual enhancement 
medication.  Lifestyle drugs do not pose the threat of addiction presented by 
controlled substance but may still be dangerous if left unregulated.129  
Finally, the Act bans the use of the internet to “advertise the sale of, or to offer to 
sell, distribute, or dispense a controlled substance.”130  This provision is a good start, 
but seems to indicate a lack of understanding from the legislators.  Google, a leading 
online advertiser, has already placed self imposed bans on advertising dangerous 
online pharmacies.131  Rather, the legislators should have attempted to regulate 
search engines, which lead consumers to dangerous online pharmacies without the 
need for the banned advertisements. 
IV.  RECOMMENDATIONS FOR FUTURE LEGISLATION 
Based on the analysis above, the Ryan Haight Online Pharmacy Consumer 
Protection Act must be amended in order to protect consumers.  Future legislation 
targeted at online pharmacy consumer protection must include regulations for search 
engines and web intermediaries, patient privacy, foreign pharmacies, lifestyle drugs 
and drug manufacturers.  
A.  Web Intermediaries 
The Ryan Haight Act appears to ignore the very medium that supports online 
pharmacies- the internet.  Although the Act now allows webhosts to shutdown 
pharmacies that are not properly registered with the DEA,132  I recommend that 
future legislation place more responsibility and accountability with web hosts, search 
engines, and credit card companies.  Domain registration companies have expressed 
                                                                 
127 United States Food and Drug Administration, http://www.fda.gov/oc/initiatives/ 
counterfeit/qa.html (last visited Dec. 5, 2008). 
128 Dispensing and Purchasing Controlled Substances over the Internet, supra note 26 at 
21184. 
129 Kansas ex rel. Stovall v. ConfiMed.com, L.L.C., 38 P.3d 707 (Kan. 2002) (Kansas 
failed to prosecute a Washington doctor under the Kansas Consumer Protection Act after 
Viagra, a sexual enhancement drug, was delivered to a 16 year old.  The trial court stated “I 
don’t have any trouble with saying. . . . these people ought to be de-frocked as medical 
practitioners, as pharmaceutical practitioners. . . ”). 
130 21 U.S.C. § 843 (2008). 
131 Google, Online Pharmacy Qualifications, http://www.google.com/adwords/pharmacy_ 
qualification.html (last visited Dec. 5, 2008).  “Google only accepts online pharmacies that are 
based in the U.S., Canada, the UK, the Republic of Ireland, Germany, the Netherlands, 
Australia, or New Zealand and have met certain conditions.”   
132 A.J. Perez, New law allows website hosts to just say no to drug, USA TODAY, Oct. 24 
2008, at C7.  
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support133 for the Ryan Haight Act and even “proposed modifications to make the 
legislation more relevant”.134 
In testimony to Congress, William K. Hubbard praised the practices of Google, 
Yahoo!, Microsoft, and America Online for their voluntary efforts to combat the 
prevalence of rogue online pharmacies.135  He further stated that the FDA has 
encouraged the cooperation of major online search engines and will continue to do 
so.136  The need to regulate web intermediaries and other internet sales facilitators is 
well documented.  Consumers will not be adequately protected from the ills of 
internet pharmacies without this crucial step.   
Former assistant secretary of state for International Narcotics Matters, Mathea 
Falco, described the complexity and depth of the role that web intermediaries play by 
stating 
[R]ogue pharmacies operating in lawless locations will continue offering 
to sell narcotics to teenagers without prescriptions -- or with the phoniest 
pretense of a prescription -- happily using the unwitting cooperation of 
U.S. search engines, Internet service providers and credit card companies. 
We need additional legislation to require the legitimate businesses that are 
key intermediaries in illegal online drug transactions to withdraw their 
assistance.137 
Falco’s concerns with web intermediaries are well founded.  Legislation should be 
established that will either penalize intermediaries that assist illegal online drug 
transactions or provide incentives to intermediaries that actively resist or take steps 
to avoid aiding illegal online transactions.  Falco offers a solution that combines 
elements of consumer education and reliance on new technology that would impose 
relatively simple requirements on search engines: 
Search engines that profit from [online pharmacies offering controlled 
substances] -- should automatically provide a banner warning that such 
purchases are illegal and describing the dangers of the drugs whenever 
searches for such terms are requested. In addition, Internet service 
providers should, in a highly public way, offer customers the use of spam 
filters to exclude from their homes offers for illegal sales of any controlled 
substance, such as prescription narcotics.138 
Falco’s solution protects internet consumers who may unknowingly break the law 
while offering parents a solution to prevent the sort of behavior that killed Ryan 
                                                                 
133 Id. 
134 Go Daddy Cheers Passage of Online Pharmacy Legislation, Drug Week, Apr. 18, 
2008.  
135 Hearing on Internet Drug Sales before the H. Comm. On Government Reform, 108th 
Congress (2004) (statement of William K, Hubbard, Associate Commissioner for Policy and 
Planning, supra note 45. 
136 Id. 
137 Mathea Falco and Philip Heymann, Fighting the Online Drug Corner, WASHINGTON 
POST, Mar. 15, 2008 at A13.  
138 Id. 
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Haight.  The filter would act as a barrier to prevent interested parties from pursuing 
or following through on advertisements from rogue pharmacies.   
B.  Patient Privacy 
Patient privacy is especially important in online transactions because often, the 
consumer faces a greater risk of financial or medical data being accessed by a third 
party than if the consumer were at a local brick and mortar pharmacy.  The National 
Association of Boards of Pharmacy offers two suggestions for consumers when 
choosing an online pharmacy based on patient privacy.  First, the website should 
encrypt any material that may identify the patient.  Next, the website should provide 
patients with a Notice of Privacy Practices for Protected Health Information.  Future 
legislation should require online pharmacies to encrypt financial and medical 
information and provide privacy notices.139 
Two larger online pharmacies, CVS and Walgreens, have extensive sections of 
their websites responding to patient privacy concerns.140  Walgreens, for example, is 
relatively open about what information is disclosed to whom.141  Walgreens’ patient 
privacy policy also suggests that Walgreens has a relatively firm grasp on the patient 
privacy risks associated with the internet.  Perhaps more importantly, Walgreens 
provides contact information for consumers who may have further inquiries and 
methods to opt out of some information disclosure programs.142  The CVS privacy 
policy is quite similar to that of Walgreens.143  CVS explains its policies regarding 
protecting and sharing information gathered from website visitors, provides contact 
information, and how it uses the information. 
Future online pharmacy patient legislation should draw heavily from existing 
patient privacy policies of successful and respected pharmacies.  Three notice 
requirements that should be formally legislated are a notice of how the information is 
stored and used, what information is collected, and to whom what information is 
disclosed.  Additionally, online pharmacies should be required to educate consumers 
about how their privacy rights may be affected through use of the site that may be 
different from privacy rights in a traditional pharmacy setting, such as “visits to the 
Site, which parts of the Site visitors select, IP address (the Internet address assigned 
                                                                 
139 National Association of Boards of Pharmacy, supra note 126. 
140 CVS/pharmacy, Help: Privacy Policy, http://www.cvs.com/CVSApp/help/privacy_ 
policy.jsp (last visited Feb. 12, 2009); Walgreens, Walgreens.com Online Privacy & Security 
Policy, http://www.walgreens.com/help/privacyandsecurity.jsp (last visited Feb. 12, 2009).   
141 Walgreens, Walgreens.com Online Privacy & Security Policy, http://www.walgreens. 
com/help/privacyandsecurity.jsp (last visited Feb. 12, 2009).  “Categories of personally 
identifiable information include: name, address, phone number, e-mail address, date of birth, 
billing/shipping information (credit card number, shipping address), and Rx number.” Id. 
142 Id. “You can always choose not to provide information.” Walgreens also provides 
relevant contact information for consumers who have additional concerns. Id. 
143 CVS/pharmacy, Help: Privacy Policy, http://www.cvs.com/CVSApp/help/privacy_ 
policy.jsp (last visited Feb. 12, 2009).  “We want you to understand how any personally 
identifiable information you provide to us is collected and used. Your personally identifiable 
information is removed before collected information is passed to the database we use to 
generate reports.”  Id. 
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to your computer from your Internet Service Provider), domain type, browser type 
(e.g., Netscape or Internet Explorer), date and time of day.”144   
Finally, legislation should establish a standard by which all online pharmacies 
must protect patient privacy.  CVS claims to use “reasonable measures”145 to protect 
patient privacy.  Reasonable measures, according to CVS, include the use of “Secure 
Socket Layer (SSL) technology . . . SSL technology provides for the safe 
transmission of personal information . . . because the information is encrypted. 
Encryption involves systematically scrambling numbers and letters so that if 
someone managed to intercept a packet of information, they would not be able to 
make sense of it.”146  Legislators should implement a flexible patient privacy 
protection standard for online pharmacies that allows for and anticipates the 
development of more powerful technology.  The standard protection must at least 
use reasonable encryption methods to protect online pharmacy patients in future 
legislation. 
C.  Foreign Pharmacies 
Foreign pharmacies are particularly troublesome because they are not subject to 
U.S. laws and regulations.  Imported drugs can be especially dangerous.147  The FDA 
estimates that up to 30% of imported drugs may be counterfeit.148  Counterfeit 
medicine is dangerous simply because consumers may be unknowingly taking life 
threatening substitutes.  For example, the FDA discovered that many consumers who 
ordered Ambien, Xanax, Lexapro, and Ativan from online pharmacies received 
products that actually contained haloperidol.149  The FDA describes haloperidol as “a 
powerful anti-psychotic drug.”150 
In 2004, the FDA took “action against three foreign internet sites associated with 
a site previously found to be selling counterfeit contraceptive patches that contain no 
                                                                 
144 CVS.com Privacy Policy, http://www.cvs.com/CVSApp/help/privacy_policy.jsp (last 
visited Apr. 15, 2010). 
145  Id. 
146 Id.  
147 United States Food and Drug Administration, http://web.archive.org/web/20080223 
155318/http://www.fda.gov/oc/initiatives/counterfeit/qa.html (last visited Apr. 15, 2010).    
148 Id. United States Food and Drug Administration, http://web.archive.org/web/2008022 
3155318/http://www.fda.gov/oc/initiatives/counterfeit/qa.html (last visited Apr. 15, 2010).   
The prevalence of counterfeit drugs in developed countries is estimated to be as low as 1%.  
The FDA asserts that the prevalence of counterfeit drugs in the United States is lower that 1%, 
not withstanding two recent and highly publicized incidents.   
149 The United States Food and Drug Administration, The Possible Dangers of Buying 
Medicine Online, supra note 58.  The side effects for haloperidol are quite serious.  The FDA 
reports that “some sought emergency medical treatment for symptoms such as difficulty in 
breathing, muscle spasms and muscle stiffness.”  The FDA has compiled a list of drugs that 
consumers should not purchase online due to safety restrictions at www.fda.gov/cder/ 
consumerinfo/dontBuyonNet.htm.  Id.  
150 Id.  
136 JOURNAL OF LAW AND HEALTH [Vol. 23:29 
active ingredients.”151  The counterfeit patches did not provide any protection against 
pregnancy.  Although outside the jurisdiction of the United States, the FDA was not 
helpless.152  The FDA “obtained the cooperation of the U.S.-based internet service 
provider in shutting down service to these sites.”153  On its own initiative, the FDA 
utilized appropriate web intermediaries to remove the foreign threat. 
The FDA has taken measures beyond consumer education and internet service 
provider cooperation.  The FDA also began issuing “cyber letters” in 2000.154  In a 
press release, the FDA explains that the cyber letters are  
electronic versions that are similar to traditional "warning" or "untitled" 
letters, which the agency has long sent to organizations or individuals it 
believes are engaged in violative activities. These letters usually outline 
the nature of the alleged violation and request a formal response [and] also 
provide[s]… foreign operators with an explanation of the statutory 
provisions that govern interstate commerce of drugs in the United States, 
as well as a warning that future shipments of their products to this country 
may be automatically detained and subject to refusal of entry.”155 
Not only are drugs from foreign based online pharmacies more likely to be 
counterfeit or unsafe,156 they are often more expensive.157  In 2003, the FDA released 
                                                                 
151 The United States Food and Drug Administration, FDA News, FDA Takes Action 
Against Foreign Websites Selling Counterfeit Contraceptive Patches, http://www.fda.gov/ 
newsevents/newsroom/pressannouncements/2004/ucm108246.htm (last visited Apr. 15, 
2010).. “[T] he counterfeits were sent in simple plastic zip-lock bags without identifying 
materials, lot numbers, expiration dating or any other labeling information needed to safely 
and effectively use this prescription product.”  Id.  
152 Id. 
153 Id. “FDA’s Office of Criminal Investigation is continuing to work with the Department 
of Homeland Security’s Bureau of Immigration and Custom Enforcement (ICE) Cyber Crimes 
Center to combat pharmaceutical counterfeiting and other illegal internet drug sales and take 
effective action against those responsible.”  Id. 
154 United States Food and Drug Administration, Cyber Letters 2008, http://www.fda.gov/ 
Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/CyberLette
rs/default.htm (last visited Oct. 30, 2009); One such cyber letter was sent to www.cura-
care.com, a website that purported to sell cancer treating creams and drugs.  On its website, 
Cura-Care.com described the effects of one its products with the following description: 
“cancer on the surface of the skin tissue is treated and the deep penetrating delivery cream 
then allows the active constituents to penetrate the skin and attack the whole cancer hidden 
beneath the skin tissue.”  Available at http://www.fda.gov/ICECI/ EnforcementActions/ 
WarningLetters/2008/ucm1048289.htm  (last visited Oct. 30, 2009).  
155FDA Talk Paper, FDA Launches “Cyber” Letters Against Potentially Illegal, Foreign 
Based Online Drug Sites, http://web.archive.org/web/20080229052621/http://www.fda.gov/ 
bbs/topics/ANSWERS/ANS01001.html (last visited Apr. 12, 2010).  At the time of the press 
release, the FDA had only received one response from the cyber letter program indicating 
compliance to cease illegal activities.   
156 Drugs imported from Mexican pharmacies contained no active ingredients, FDA Talk 
Paper, FDA Warns Consumers About Counterfeit Drugs Purchased in Mexico, 
http://web.archive.org/web/20080223122244/http://www.fda.gov/bbs/topics/ANSWERS/2004
/ANS01303.html (last visited Apr. 12, 2010).   
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a statement proclaiming “[i]n the U.S., generic drugs, which comprise roughly half 
of all prescriptions, are cheaper than both Canadian branded drugs and Canadian 
generic drugs.”158  In an examination of over 2000 drug packages at the United States 
border, “47 percent of the sampled products can be bought for $4 at several national 
chain pharmacies, a price often lower than the shipping costs for the same drugs 
purchased online.”159   
Existing regulations in the Controlled Substance Act already prohibit importing 
controlled substances.160  Because drugs are still commonly imported anyway, some 
scholars have made some unconventional suggestions ranging from simply lowering 
the cost of prescription costs in the United States161 to forming an international 
coalition of online pharmacies.162  While there is debate as to the foreign pharmacy 
solution, federal legislators must not continue to ignore the problem.   
D.  Lifestyle Drugs 
Lifestyle drugs are among the most popular items on online pharmacies.  
Examples of lifestyle drugs include weight loss and sexual enhancement drugs, 
which are not regulated by the Controlled Substances Act.163   While drugs of this 
                                                                                                                                         
157 Food and Drug Administration, U.S./Canadian Price Comparisons October 2004, 
http://web.archive.org/web/20080504232457/http://www.fda.gov/oc/opacom/hottopics/import
drugs/canadarx.html (last visited Apr. 12, 2010).  The chart compiled by the FDA indicates 
that for many consumers, drugs purchased domestically are far less expensive.  The prices for 
the Canadian drugs do not include a shipping charge, which is usually between $15.00 - 
$30.00.  Id.  
158 Food and Drug Administration, FDA White Paper, Generic Drug Prices in the U.S. Are 
Lower Than Drug Prices in Canada, http://web.archive.org/web/20080223160716/http:/ 
/www.fda.gov/oc/whitepapers/drugprices.html (last visited Apr. 12, 2010). “In the U.S., 
generic drugs, which comprise roughly half of all prescriptions, are cheaper than both 
Canadian branded drugs and Canadian generic drugs.” Id.  
159 Food and Drug Administration, FDA News, FDA Says Consumers Continue to Buy 
Risky Drugs Online, http://web.archive.org/web/20080223200918/http://www.fda.gov/bbs/ 
topics/NEWS/2007/NEW01735.html (last visited Apr. 12, 2010).  The FDA conducted a study 
of drugs mailed to consumers from outside the United States.  Most of the drugs purchased by 
consumers were domestically available and several had inexpensive generic versions.  The 
FDA’s deputy commissioner for policy suggests that “‘many people are buying drugs online 
not to save money but to bypass the need for a prescription from their doctor since these Web 
sites typically do not require the purchaser to have a prescription’”.  Id.  
160 21 U.S.C. § 952 (2006). “It shall be unlawful to import . . .  into the United States from 
any place outside thereof, any controlled substance in schedule I or II. . . [or] [n]onnarcotic 
controlled substances in schedule III, IV, or V.” Id.  
161 Ayers, supra note 5. 
162Yoo, supra note 5. 
163 Dispensing and Purchasing Controlled Substances over the Internet, supra note 26;  See  
Drug Enforcement Administration, Office of Division Control, Questions and Answers: 
Dispensing and Purchasing Controlled Substances Over the Internet, supra note 58.  “Some 
people have applied the phrase ‘lifestyle drugs’ to certain medications, such as Viagra, weight 
control medications, and tranquilizers.  Many of these so-called life style drugs are not 
controlled substances.”  
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type do not typically present a danger of addiction, they may still pose a danger to 
individuals with medical complications.164  Lifestyle drugs, especially weight loss 
and sexual enhancement drugs, are potentially dangerous to consumers with health 
problems. 
In Kansas ex rel. Stovall v. ConfiMed.com, L.L.C., an attorney general was able 
to enjoin an out of state vendor from selling and dispensing medication to Kansas 
residents after a sixteen year old obtained Viagra through an online questionnaire.  
Ordinarily, teens would be unable to obtain Viagra without first consulting with a 
physician.  With the help of the internet, the teen was able to easily purchase the 
Viagra. The Attorney General was hampered in his attempts to punish the vendor.  In 
the absence of legislation targeted at online pharmacies dispensing lifestyle drugs, 
the Attorney General was forced to pursue a prosecution for unconscionable acts 
under the Kansas Consumer Protection Act.  The attempt failed, and the vendor was 
spared of any meaningful consequences.165 
Weight loss pills and sexual enhancement and erectile dysfunction pills are 
targeted toward online consumers, often for privacy reasons. Consumers purchasing 
weight loss or erectile dysfunction tablets may not want to be seen buying said 
products at the local pharmacy, so they turn to the all too anonymous realm of online 
pharmacies.  The problem, however, is that because lifestyle drugs (also sometimes 
called “dietary supplements”) are not subject to prescription or controlled substance 
requirements, there is often little regulation to protect the consumer.166   
Men, the FDA warns, should take care when ordering so called “dietary 
supplements” because they often “contain prescription drugs or other undisclosed 
ingredients that can be harmful.”167  The FDA found that more than one third of the 
dietary supplements that claimed to increase sexual enhancement contained 
prescription drug ingredients.168  Undisclosed prescription drug ingredients can be 
                                                                 
164 Lifestyle Drug Binge, Businessweek.com, http://www.businessweek.com/magazine/ 
content/07_27/b4041048.htm (last visited Mar. 24, 2009).  “On June 13 a panel of FDA 
advisers voted unanimously not to recommend a weight-loss treatment called Acomplia . . . 
.Though it is already approved in 37 countries, the FDA and its advisers are concerned about 
reports linking it to depression and even suicidal tendencies.” Id.  
165 ConfiMed.com, L.L.C., 38 P.3d at 707 (failure to perform physical examination or 
provide actual physical supervision and Viagra sale to a minor was not unconscionable). 
“[F]inding . . . that there was no actual harm, nothing was misrepresented, and the product 
furnished was authentic conclusively shows that potential unconscionable acts outside the 
enumerated examples of [Kansas Consumer Protection Act] were considered.” Id. 
166 See generally Paula Kurtzweil, An FDA Guide to Dietary Supplements, http://www. 
fda.gov/FDAC/features/1998/598_guid.html (last visited Mar. 24, 2009).   
167 United States Food and Drug Administration, Buying Fake ED Products Online, 
http://web.archive.org/web/20080221175443/http://www.fda.gov/consumer/updates/erectiledy
sfunction010408.html (last visited Feb. 12, 2009).  “Men looking online for ‘dietary 
supplements’ to treat erectile dysfunction (ED) or enhance their sexual performance should 
beware: these products may contain prescription drugs or other undisclosed ingredients that 
can be harmful.”  Id.  
168 Id. “Six of the 17 products we bought contained sildenafil (the active ingredient in 
Viagra) or a substance similar to either sildenafil or vardenafil,’ says [Linda Silvers, leader of 
FDA's Internet and Health Fraud Team]. Vardenafil is the active ingredient in Levitra, another 
FDA-approved prescription drug that treats ED.” Id.  
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potentially dangerous for consumers with “diabetes, high blood pressure, high 
cholesterol, or heart disease.”169  On a similar note, the FDA released a list of 
recalled dietary supplements that were advertised as weight loss pills.170  The weight 
loss pills, most of which were obtained from online pharmacies, were recalled 
because “they contain undeclared ingredients and, in some cases, contain 
prescription drugs in amounts that greatly exceed their maximum recommended 
dosages.”171 As it stands, the Ryan Haight Act will not do anything to regulate the 
trade of lifestyle drugs or dietary supplements via online pharmacies.  Congress must 
address dangerous distribution of medication by irresponsible online pharmacies. 
E.  Drug Manufacturers 
As the ultimate source of prescription medication, legislators must not ignore the 
role that drug manufacturers play in allowing drugs to be readily distributed by 
dangerous online pharmacies.  Kelly v. Qualitest Pharmaceuticals, Inc. involved a 
surviving family member and a drug manufacturer in a wrongful death suit.  The 
Kelly court provided a detailed description of the dangerous relationship between 
drug manufacturers and online pharmacies. 
Online pharmacies . . . are able to purchase virtually unlimited supplies of 
controlled substances from manufacturers… which employ specific 
distributors to market the manufacturer’s products.  The distributors, with 
the authority of the manufacturer, allow the drugs which are 
governmentally regulated because of the dangers the drugs present if 
improperly used, to enter the stream of commerce unrestrained.”172 
Later in the opinion, the court declined to extend tort liability to the manufacturer 
because “[i]t does not appear that Qualitest was a party to the on-line transaction, 
                                                                 
169 United States Food and Drug Administration, Buying Fake ED Products Online, 
Http://www.fda.gov/consumer/updates/erectiledysfunction010408.html (last visited Feb. 12, 
2009).   The FDA provides a list of erectile dysfunction products sold online to avoid.  The list 
is available at http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm048386.htm Id.  
170 Food and Drug Administration, FDA News, FDA Expands Warning to Consumers 
About Tainted Weight Loss Pills, http://www.fda.gov/NewsEvents/Newsroom/Press 
Announcements/2008/ucm116998.htm (last visited Feb. 12, 2009). “December 22, 2008, FDA 
warned consumers not to purchase or consume 28 different products marketed for weight loss. 
Since that time, FDA analysis has identified 41 more tainted weight loss products that may put 
consumers’ health at risk.”  Id.  
171 Id. “An FDA analysis found that the undeclared active pharmaceutical ingredients in 
some of these products include sibutramine (a controlled substance), rimonabant (. . .  not 
approved for marketing in the United States), phenytoin (an anti-seizure medication), 
phenolphthalein (. . . used in chemical experiments and a suspected cancer causing agent) and 
bumetanide (a diuretic).”  Id.  
172 Kelly v. Qualitest Pharms., Inc., 2006 U.S. Dist. LEXIS 65814 (E.D. Cal. Aug. 28, 
2006), at *4 (Plaintiff’s allegation that Defendant was “negligent in the sales, distribution, and 
control of the dangerous and controlled substance . . . [and] approved the sale . . .  to . . .  
‘rogue’ pharmacies without reasonable investigation into the business practices of the 
pharmacy. . . [and] did not require proof of proper licensing of the business, its pharmacists or 
physicians” was dismissed for lack of proper venue).  
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rather, the only apparent role that Qualitest played was manufacturing [the drug].”173  
If online pharmacies are to be safely regulated, their source for these medications 
must be controlled.  In order to create truly effective online pharmacies, drug 
manufacturers must be required to conduct “a reasonable investigation into the 
practices, licensure, and insurance status of the pharmacies”174 before shipping or 
selling medication to online pharmacies.   
I recommend that future federal online pharmacy regulation should be modeled 
after the California statute cited in Kelly.175  The statute reads, in part, “No 
wholesaler or manufacturer … shall furnish controlled substances for other than 
legitimate purposes.”176  California defines mens rea177 as “knowing, or having 
conscious disregard for the fact, that the controlled substances are for other than a 
legitimate medical purpose . . . .”178  If adopted on a federal level, this statute would 
impose a duty on drug manufacturers to sell controlled substances to legitimate 
online pharmacies.  If taken further, future legislation could limit the sale of 
controlled substances solely to DEA endorsed pharmacies. 
V.  WHY THE RYAN HAIGHT WILL BE SUCCESSFUL 
The Ryan Haight Act will likely be successful in regulating online pharmacies 
because other industries have succeeded in the transition from brick and mortar to an 
online presence.  The Ryan Haight Act legislation represents themes of consumer 
rights and protection, a transition to federal regulation, a transition to internet-based 
services and the growing recognition of the need for regulation to keep pace with 
advances in technology.   These themes are consistent with successful legislation 
exemplified in other sectors. 
A.  Online Banking 
The transition of the banking industry away from brick and mortar to online 
banking179 draws many similarities to the transition that pharmacies are undergoing.   
The regulation of online banking, like that of online pharmacies, strives to put brick 
and mortar institutions on the same ground as online entities. One method of 
                                                                 
173 Id. at *31. 
174 Id. at *28. 
175 Cal. Health & Saf. Code § 11153.5 (1988). 
176 Id.  
“Factors to be considered in determining . . .  [mens rea] shall include, but not be limited 
to, whether the use of controlled substances was for purposes of increasing athletic ability or 
performance, the amount of controlled substances furnished, the previous ordering pattern of 
the customer (including size and frequency of orders), the type and size of the customer, and 
where and to whom the customer distributes the product.” Id. 
177 Black's Law Dictionary (8th ed. 2004), mens rea. Black’s Law Dictionary defines mens 
rea as “The state of mind that the prosecution, to secure a conviction, must prove that a 
defendant had when committing a crime.” Id.  
178 Cal. Health & Saf. Code§ 11153.5 
179 Online banking as extension of brick and mortar banks are often called “bricks and 
clicks” banking. 
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achieving this has been to amend a successful regulatory framework that is already in 
place to reflect technological advances.  Just as the Ryan Haight Act amended the 
Controlled Substances Act, the Federal Reserve’s lettered regulations have been 
amended to reflect changes in technology.  For example, “Regulation E” was 
implemented to regulate electronic fund transfers.180 
To the consumer, online banking offers many of the same advantages and risks 
associated with online pharmacies.  The advantages in online banking revolve 
around convenience, efficiency, speedy transactions, and the ability to bank from 
anywhere with internet access.  The risks, although not life threatening, are still very 
serious.  The risks of online banking revolve around trust and the potential of fraud.  
To address the risks, a great deal of banking regulation has been geared toward 
consumer protection and disclosure requirements.  The Federal Deposit Insurance 
Corporation (FDIC) published a brochure to educate consumers on how to avoid the 
perils of online banking181 that seems to mirror many of the consumer education 
publications put out by the FDA182 and DEA.183  
The similarity between the efforts of online banking regulations and online 
pharmacy regulations are striking.  In its brochure, the FDIC warns consumers to 
“[c]onfirm that an online bank is legitimate and that your deposits are insured, [k]eep 
your personal information private and secure, [u]nderstand your rights as a 
consumer, and [l]earn where to go for more assistance from banking regulators.”184 
With the exception of privacy, the above requirements look as if they were drawn 
from the Ryan Haight Act.  In both banking and pharmacies, online trust is 
established through the use of an endorsing agency, be it the FDIC or DEA.  
Next, banks are required to make certain disclosures, exemplified by the Truth in 
Lending act.  The Truth in Lending Act requires banks to disclose lending terms and 
arrangements – which are essential to informing and protecting the consumer 
concerning banking practices.185  The Ryan Haight Act also requires disclosure of 
information essential to the safe and successful operation of a pharmacy dispensing 
                                                                 
180 12 C. F. R. § 205.1, et seq. (1996).  The amendment to Regulation E “establishes the 
basic rights, liabilities, and responsibilities of consumers who use electronic fund transfer 
services and of financial institutions that offer these services. The primary objective of the act 
and this part is the protection of individual consumers engaging in electronic fund transfers.”  
Id. 
181 Federal Deposit Insurance Corporation, Safe Internet Banking, http://www.fdic.gov/ 
BANK/INDIVIDUAL/ONLINE/safe.html (last visited Feb. 12, 2009). “As use of the Internet 
continues to expand, more banks . . .  are using the Web to offer products and services . . . [to] 
consumers. The Internet offers the potential for safe, convenient new ways to shop for 
financial services and conduct banking business, any day, any time. However, safe banking 
online involves making . . .  decisions that will help you avoid costly surprises or even scams.”  
Id. 
182 Buying Prescription Medicine Online: A Consumer Safety Guide, http://www.fda.gov 
/buyonlineguide/ (last visited Feb. 12, 2009). 
183 See Dispensing and Purchasing Controlled Substances over the Internet, supra note 26 
184 Federal Deposit Insurance Corporation, Safe Internet Banking, http://www.fdic.gov/ 
BANK/INDIVIDUAL/ONLINE/safe.html (last visited Feb. 12, 2009). 
185 See generally 15 U.S.C. § 1601 et seq. (1968). 
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potentially deadly drugs, such as the name of the pharmacist and how to contact the 
pharmacy.   
Banking’s track record of successful regulation, smooth transition onto the 
internet, and emphasis on consumer protection, demonstrate that federal regulation 
may be appropriate for online activities that were once only done in brick and mortar 
facilities, such as purchasing and selling medication.  Additionally, many of the 
consumer regulations in the banking industry, such as disclosure and the use of an 
endorsing agency, are parallel to the consumer regulations in the Ryan Haight Act.  
The continued growth in online banking demonstrates that consumers are willing to 
make the transition to online entities when proper consumer protection exists. 
B.  Increasing Role of the Internet 
For both legislators and the public at large, it is becoming harder and harder to 
ignore the influence of the internet. The internet is fast becoming ubiquitous as its 
presence seems to increase daily.  According to the Pew Internet & American Life 
Project, an initiative of the Pew Research Center, more than half of American 
households have high-speed internet access.186  The Pew Internet & American Life 
Project also reports that the fastest growing group of internet users is over 70 years 
old.187  It is not unreasonable to assume that an increasing population of seniors on 
the internet will contribute to the growth of online pharmacies.  As the percentage of 
the population that may be exposed to potentially dangerous online pharmacies 
grows, the demand for effective regulation will become harder to ignore. 
VI.  CONCLUSION 
In sum, The Ryan Haight Online Consumer Protection Act of 2008 is a much 
needed first step toward meaningful regulation of online pharmacies.  The DEA 
registration, efforts to increase online pharmacy transparency, public notice and 
balance, serve as strengths of the Act.  However, several of the Act’s shortcomings 
must be addressed in future legislation.  Improvements for future legislation must 
address aspects of online pharmacies unique to the internet, such as web 
intermediaries, web hosts, and patient privacy concerns.  The regulation must also be 
expanded to include readily available and often dangerous lifestyle drugs.  Larger 
problems, such as the liability of drug manufacturers and foreign pharmacies must 
also be addressed in any future legislation.    
 
                                                                 
186 Pew Internet and American Life Project, Home Broadband 2008, http://www.pew 
internet.org/PPF/r/257/report_display.asp  (last visited Feb. 12, 2009).  The Pew Internet and 
American Life Project reports that in 2008, 55% of Americans had high-speed internet access, 
up from 47% in 2007.  Id.  
187SeniorJournal.com - Senior Citizens Information and News, Senior Citizens and 
Internet, http://www.seniorjournal.com/NEWS/WebsWeLike/2009/20090207-FastestGrowing 
.htm (last viewed Feb. 12, 2009);  Sydney Jones, Pew Research Center Publications, 
Generations Online in 2009, http://pewresearch.org/pubs/1093/generations-online (last visited 
Feb. 12, 2009).  
